Article
Atlanta-A trial of drug regimens in hormone-refractory prostate cancer came up with only modest results, but it did take an important first step: It is one of the first prospective trials conducted in taxane-refractory disease.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.